The value of multimodal ultrasound imaging in differentiating HER2-positive breast cancer | Synapse
March 3, 2026Open Access
The value of multimodal ultrasound imaging in differentiating HER2-positive breast cancer
Puntos clave
Multimodal ultrasound improves diagnostic efficacy for HER2-positive breast cancer, leading to better identification of patients.
The combination of CUS, CEUS, and SRUS provides higher accuracy than any single modality for detecting HER2-positive tumors.
Analysis utilized advanced imaging parameters from diverse ultrasound techniques, refining assessment methods in oncology.
Findings suggest integrating multimodal approaches could enhance breast cancer screening and management strategies.
Resumen
Multimodal ultrasound parameters from CUS, CEUS, and SRUS can predict HER2-positive breast cancer, and their combination provides superior diagnostic efficacy.